INNOVATEive omalizumab therapy effective in difficult-to-treat asthma

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1488, 2005-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Omalizumab is an effective add-on therapy in moderate-to-severe allergic asthma

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 7, 2005-07 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Omalizumab effective in allergic asthma and allergic rhinitis

By  

Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Ixabepilone indicates activity in difficult-to-treat breast cancers

By  

Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Rituximab benefits difficult-to-treat patients with RA

By  

Inpharma, Vol. 1, Iss. 1523, 2006-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Omalizumab - systemic asthma and rhinitis therapy in the new millennium

By  

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite